Please use this identifier to cite or link to this item:
|Title:||Polymer- and lipid-based nanoparticle therapeutics for the treatment of liver diseases||Authors:||Li, L.
Hepatitis B virus infection
Hepatocellular carcinoma (HCC)
|Issue Date:||Aug-2010||Citation:||Li, L., Wang, H., Ong, Z.Y., Xu, K., Ee, P.L.R., Zheng, S., Hedrick, J.L., Yang, Y.-Y. (2010-08). Polymer- and lipid-based nanoparticle therapeutics for the treatment of liver diseases. Nano Today 5 (4) : 296-312. ScholarBank@NUS Repository. https://doi.org/10.1016/j.nantod.2010.06.007||Abstract:||Liver diseases, particularly hepatitis B virus infections, liver cirrhosis and hepatocellular carcinoma continue to pose a significant health challenge worldwide due to the dire lack of curative treatment options besides liver resection and transplantation. Nanoparticle therapeutics, comprising of drugs, nucleic acids or proteins in association with a carrier, have emerged as safe and efficient systems in the treatment of the respective liver diseases. This review describes targeting strategies employed in relation to liver anatomy and disease etiologies, summarizes recent advances in the field and discusses the challenges and future perspectives for the effective treatment of liver diseases using polymer- and lipid-based nanoparticle therapeutics. © 2010 Elsevier Ltd.||Source Title:||Nano Today||URI:||http://scholarbank.nus.edu.sg/handle/10635/106695||ISSN:||17480132||DOI:||10.1016/j.nantod.2010.06.007|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Apr 4, 2020
WEB OF SCIENCETM
checked on Mar 19, 2020
checked on Mar 28, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.